← All organizations
Highest phase reached
Phase 4
First clinical trial
May 1, 2014Last known activity
Jun 27, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (7 distinct, 5 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (10)
- NCT07170475Lead sponsorPhase 1Jun 27, 2025
- NCT04863131Lead sponsorPhase 1/Phase 2Apr 28, 2021
- NCT04863131Overall official - principal investigatorPhase 1/Phase 2Apr 28, 2021
- NCT04863131Reponsible party - principal investigatorPhase 1/Phase 2Apr 28, 2021
- NCT05117866Overall official - principal investigatorN/ASep 15, 2020
- NCT05117866Overall official - principal investigatorN/ASep 15, 2020
- NCT05117866CollaboratorN/ASep 15, 2020
- NCT02615249Overall official - principal investigatorPhase 2Apr 1, 2016
- NCT02024230Reponsible party - principal investigatorPhase 4May 1, 2014
- NCT02024230Lead sponsorPhase 4May 1, 2014
Details
- Last known activity
- Jun 27, 2025